BR112019018088A2 - Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados - Google Patents
Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados Download PDFInfo
- Publication number
- BR112019018088A2 BR112019018088A2 BR112019018088-5A BR112019018088A BR112019018088A2 BR 112019018088 A2 BR112019018088 A2 BR 112019018088A2 BR 112019018088 A BR112019018088 A BR 112019018088A BR 112019018088 A2 BR112019018088 A2 BR 112019018088A2
- Authority
- BR
- Brazil
- Prior art keywords
- purified
- propositally
- canabinoids
- terpens
- understand
- Prior art date
Links
- 0 *COCCCC(CC1)CC(*)C1O Chemical compound *COCCCC(CC1)CC(*)C1O 0.000 description 7
- BNNRVPJBPOYHGF-UHFFFAOYSA-N CCCCCC(C)([CH2+])N Chemical compound CCCCCC(C)([CH2+])N BNNRVPJBPOYHGF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyrane Compounds (AREA)
Abstract
são aqui reveladas novas composições que compreendem um canabinoide purificado e um terpeno purificado. em uma modalidade, as composições compreendem um ou mais canabinoides purificados. em uma modalidade, as composições compreendem um ou mais canabinoides purificados em combinação com um ou mais terpenos purificados. em uma modalidade, as composições compreendem razões de ocorrência não natural. em uma modalidade, as composições compreendem concentrações de ocorrência não natural. em uma modalidade, as composições compreendem efeitos inesperados e/ou sinérgicos.
Applications Claiming Priority (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465688P | 2017-03-01 | 2017-03-01 | |
US62/465.688 | 2017-03-01 | ||
US201762469415P | 2017-03-09 | 2017-03-09 | |
US62/469.415 | 2017-03-09 | ||
US201762475153P | 2017-03-22 | 2017-03-22 | |
US62/475.153 | 2017-03-22 | ||
US201762477990P | 2017-03-28 | 2017-03-28 | |
US62/477.990 | 2017-03-28 | ||
US201762489360P | 2017-04-24 | 2017-04-24 | |
US62/489.360 | 2017-04-24 | ||
US201762490465P | 2017-04-26 | 2017-04-26 | |
US201762490567P | 2017-04-26 | 2017-04-26 | |
US62/490.567 | 2017-04-26 | ||
US62/490.465 | 2017-04-26 | ||
US201762491160P | 2017-04-27 | 2017-04-27 | |
US201762491175P | 2017-04-27 | 2017-04-27 | |
US62/491.175 | 2017-04-27 | ||
US62/491.160 | 2017-04-27 | ||
US201762491980P | 2017-04-28 | 2017-04-28 | |
US201762491899P | 2017-04-28 | 2017-04-28 | |
US62/491.899 | 2017-04-28 | ||
US62/491.980 | 2017-04-28 | ||
US201762509651P | 2017-05-22 | 2017-05-22 | |
US62/509.651 | 2017-05-22 | ||
US201762510229P | 2017-05-23 | 2017-05-23 | |
US62/510.229 | 2017-05-23 | ||
US201762510660P | 2017-05-24 | 2017-05-24 | |
US201762510672P | 2017-05-24 | 2017-05-24 | |
US62/510.672 | 2017-05-24 | ||
US62/510.660 | 2017-05-24 | ||
US201762511218P | 2017-05-25 | 2017-05-25 | |
US62/511.218 | 2017-05-25 | ||
US15/616.874 | 2017-06-07 | ||
US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
PCT/US2018/020440 WO2018160827A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019018088A2 true BR112019018088A2 (pt) | 2020-03-24 |
Family
ID=63370542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019018088-5A BR112019018088A2 (pt) | 2017-03-01 | 2018-03-01 | Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3589129A4 (pt) |
CN (1) | CN110582206A (pt) |
AU (1) | AU2018227544A1 (pt) |
BR (1) | BR112019018088A2 (pt) |
CA (1) | CA3054690A1 (pt) |
CO (1) | CO2019009413A2 (pt) |
IL (1) | IL268929A (pt) |
MX (1) | MX2019010370A (pt) |
PE (1) | PE20200383A1 (pt) |
WO (1) | WO2018160827A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3743055B1 (en) | 2018-01-23 | 2024-03-06 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds |
IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
CA3148236A1 (en) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
CN114980882A (zh) * | 2019-11-26 | 2022-08-30 | 乐康瑞德有限公司 | 大麻素和番茄红素抗炎协同组合 |
WO2021220208A1 (en) * | 2020-04-29 | 2021-11-04 | Ligar Limited Partnership | Imprinted polymers and methods for their use |
EP4188915A1 (en) * | 2020-07-27 | 2023-06-07 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
US20240342197A1 (en) * | 2021-01-29 | 2024-10-17 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
WO2023245185A1 (en) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprising cannabinoids and methods of preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
EP3071193B1 (en) * | 2013-11-20 | 2020-01-08 | Panag Pharma Inc. | Compositions and methods for treatment of ocular inflammation and pain |
CA2977802A1 (en) * | 2015-02-27 | 2016-09-01 | Ebbu, LLC | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
-
2018
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/en not_active Withdrawn
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/en unknown
- 2018-03-01 CA CA3054690A patent/CA3054690A1/en active Pending
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL268929A (en) | 2019-10-31 |
EP3589129A1 (en) | 2020-01-08 |
EP3589129A4 (en) | 2020-11-25 |
CN110582206A (zh) | 2019-12-17 |
CO2019009413A2 (es) | 2019-09-09 |
MX2019010370A (es) | 2019-10-22 |
WO2018160827A1 (en) | 2018-09-07 |
AU2018227544A1 (en) | 2019-08-29 |
CA3054690A1 (en) | 2018-09-07 |
PE20200383A1 (es) | 2020-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019018088A2 (pt) | Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados | |
BR112017018316A2 (pt) | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral | |
BR112017017217A2 (pt) | ?composição que compreende ramnolipídeo e siloxano? | |
MX2019000427A (es) | Formas de dosificacion oral de cannabinoide de alta concentracion. | |
CL2017002335A1 (es) | Composiciones de cosmetica topica para combatir radicales libres | |
BR112017018276A2 (pt) | ?composição que compreende peptidase e biotensoativo e seu uso? | |
CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
BR112017004826A2 (pt) | terapias de combinação de inibidores de alk | |
PH12019501323A1 (en) | Compositions comprising sulfated polysaccharides | |
PE20200338A1 (es) | Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil | |
AR100562A1 (es) | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal | |
BR112018070060A2 (pt) | composições para tratamento bucal com uma exibição de sabor eficiente | |
MX2016014509A (es) | Formulacion de vitamina soluble en grasa. | |
BR112015029987A8 (pt) | Beta-caseína a2 e a prevenção de inflamação do intestino | |
BR112017006180A2 (pt) | composições de redução de mau odor | |
BR112018003780A2 (pt) | composições que compreendem um composto de urolitina | |
BR112017019352A2 (pt) | composições tópicas comprimidas a corticosteróide aplicações relacionadas | |
BR112017008962A2 (pt) | proteínas de fusão inibidoras de c1 esterase e usos das mesmas | |
BR112021019262A2 (pt) | Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose | |
UY38284A (es) | Composiciones y métodos para agonizar el receptor cb2 | |
BR112018068817A2 (pt) | beta-caseínas e função cognitiva | |
CL2019000174A1 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d. | |
BR112017018618A2 (pt) | odorizante de osmanthus | |
CO2020003134A2 (es) | Moduladores de la expresión de enac | |
BR112018013558A2 (pt) | método de tratamento de uma doença hepática em um indivíduo, método de uso de um inibidor de caspase, método para diminuir ou sustentar uma classificação meld ou seus componentes, método para tratar, diminuir ou sustentar uma classificação meld ou seus componentes, método para tratar, diminuir ou sustentar uma classificação de child-pugh ou seus componentes, composição farmacêutica que compreende um inibidor de caspase, kit, método de tratamento, método de tratamento de cirrose hepática e prevenção de uma classificação meld elevada, método de tratamento de cirrose hepática e prevenção de uma classificação de child-pugh elevada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |